23
Total investments
7
Early stage
5
Mid stage
2
Late stage
13y
Years active
Portfolio
16 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member and Investor
Dec 2024
Seraphic is a leader in the rapidly growing Enterprise Browser Security market, driven by its patented technology that turns any browser into a secure browser with robust protection and detection capabilities.
Seamlessly and easily deployed, Seraphic also enables secure access to SaaS and private web applications to employees and third parties from managed and personal devices without the complexity and cost of VDI & VPN. Invisible to the end-user, Seraphic supports all browsers and SaaS desktop applications like Teams, Slack, Discord, and WhatsApp.
In January 2025, Seraphic announced raising $29 million in series A funding, with participation from the CrowdStrike Falcon Fund.
L
Board Member and Investor, Linus Bio
Mar 2022
Linus Biotechnology is a patient-centric, breakthrough science, precision exposome medicine company. Our program pipeline comprises precision exposome medicine biomarkers and target discovery across disease domains for which historically no molecular endpoints have been available in medical practice or for clinical trials, including CNS (autism spectrum disorder, amyotrophic lateral sclerosis), gastroenterology (inflammatory bowel disease), renal disease and oncology.
Board Member and Investor
Mar 2022
Time to market can make or break any app dev project. Yet many enterprises, agencies, and developers slow innovation by burning countless hours building core functionality from scratch and extending development timelines.
But when you use the Onymos Features-as-a-Service platform, you get the features your app needs out of the box — and you can move fast from day one.
Founded in 2017 and based in Palo Alto, California, Onymos Features are deployed in apps on millions of devices today.
To learn more, please visit our website: www.onymos.com
Board Member and Investor
Dec 2021
Were not a workforce management tool – were a workforce empowerment tool. As the leading cloud-based solution for the gig economy, Nowsta streamlines how businesses hire, schedule, and manage their flex workforce. Trusted by some of the largest brands in professional sports, hospitality, staffing, and more, Nowsta’s centralized platform is the fastest and easiest way to source workers, hire employees, organize schedules, track time & attendance, and improve communication. Founded in 2016, Nowsta’s mission is to equip both workers and businesses with an all-in-one platform to simplify and humanize staffing and labor-management processes, creating seamless, meaningful work experiences for the flex economy.
Board Member
Feb 2021
Excision BioTherapeutics is a private company focused on developing advanced gene editing therapeutics to address the medical need for the treatment of life-threatening disease caused by viral infections. Our mission is to advance gene editing therapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world.
R
Board Member
Feb 2021
Roviero has created AI Processor accelerator IP and associated software stack as a solution that scales across multiple applications. Roviero has solved the ultimate problem of scalability, programmability, power consumption with a hybrid approach to Hardware-Software.
The IP is available today to integrate into our customers SOC. Roviero is delivering FPGA based platforms today along with the software. The FPGA platform can be used by customers to start developing real time applications while the SOC evolves - no more waiting for the SOC to develop real applications. Roviero provides the driver/application reference as open source code for customers to add their own applications to it.
Board Member
Jan 2020
KlearNow.AI started in 2018 as an AI-powered licensed customs broker transforming how businesses navigate the complexities of trade management. As global supply chains face increasing disruptions, evolving tariffs, and mounting compliance challenges, KlearNow.AI offers a platform that simplifies and automates trade operations. By eliminating manual, paper-heavy processes and requiring no complex integration, KlearHub enables importers, exporters, and supply chain partners to gain real-time, SKU-level visibility and centralized global command center of their trade data.
The platform delivers a comprehensive suite of capabilities, including digitization of customs documents, tariff impact analytics, carrier-agnostic inventory tracking, and automated pre and post entry compliance audits. Trusted by over 2,000 customers worldwide—including Fortune 100 companies—KlearNow.AI is redefining global customs and trade management with intelligent automation and resilient data orchestration.
Board Member and Investor
2019
At Activ Surgical, our mission is for every surgical imaging system to deliver intelligent information that reduces surgical complication rates, ushering in a new standard of patient care and safety. Having completed the world’s first autonomous robotic surgery of soft tissue in 2018, the company is focused on enhanced, real-time visualization capabilities for surgeons that combine advanced augmented reality (AR), artificial intelligence (AI), and machine learning (ML) technology. Our vision is to transform the collective surgical experience by leveraging emerging technologies and data into insights that make world-class surgery accessible for all.
Board Member and Investor
2019
Everyone wants fast AI.
Everyone needs cheap AI.
At Tensordyne, we are driven by one defining challenge: How do we build the architecture that delivers both?
We design AI chips and rack-level systems purpose-built for ultra-fast and ultra-efficient data center inference. We build rapidly, iterate constantly, and we are about to deploy our technology into the real world to change the trajectory of AI compute.
We are in a high-growth phase and looking for brilliant minds who thrive on autonomy and tangible impact. With a global footprint spanning the heartlands of Silicon Valley and Europe, our reach is wide and our momentum is accelerating.
Check out our careers page at https://www.tensordyne.ai/careers
Board Member and Investor
Aug 2018
The ultimate platform for embedded finance products, marketplaces, media and data
Engine by MoneyLion (formerly Even Financial), the category-leading embedded finance marketplace platform, matches consumers with real-time, personalized financial product recommendations from the largest connected network of top providers, on mobile apps, websites, and other consumer touchpoints. Engine by MoneyLion is the Enterprise brand of MoneyLion, a leader in financial technology, powering the next generation of personalized products and content
Learn more at www.engine.tech
ML Enterprise Inc. (formerly Even Financial Inc.) NMLS# 1475872 https://nmlsconsumeraccess.org
Board Member and Investor
Oct 2017
Our mission is to provide unprecedented access to blood testing.
We enable sustainable healthcare with accessible blood testing for a healthier you.
Board Member and Investor
Jan 2017
Wandz.ai is a real-time adaptive customer experience platform that enables top global brands to transform every customer experience into an adaptive journey. By combining in-session, non-PII data collection with real-time inference and predictive analytics, brands can anticipate visitors intent and next actions to craft the ultimate adaptive customer experiences.
Board Member and Investor
Dec 2016
Cognitive Operational Systems, Inc. (COSY) is a spinout of UPenns GRASP Laboratory. The company focuses on leveraging University research for enabling industry solutions in computer vision, perception, and artificial intelligence. COSY’s “ beacon-free" backend technology provides localization and turn-by-turn navigation in environments with no GPS - like indoors. This back-end technology can be used to enable augmented reality interfaces, audio-based navigation aids for the blind, and even mobile robots.
Early stage Investor and Board Member
Jun 2016
ScoreData helps businesses leverage their data to dramatically improve the quality of their engagement with their customers. The easy-to-use and simple-to-deploy nature of ScoreData’s Scorefast™ platform enables data scientists and business managers to create the most effective run-time consumer scores for fraud detection, churn-management, caller-agent mapping, recommendations and cross-sell applications. We leverage the most up-to-date best-of-breed open-source technologies.
ScoreFast™ helps bring new data models to market in record time, and fosters collaboration among your business managers to build a broad range of enterprise applications. Our self-learning models ensure that hitherto expensive model building and updates will happen automatically thus dramatically lowering total cost of ownership. You can build your business insights by combining legacy models with newer data models and new data.
If you are a business that seeks to track consumer behavior, and want to match consumers with your most optimal products or offers that meet their needs, or you are a business that is seeking to optimize workloads in the delivery chain without compromising customer satisfaction, then we have a solution for you. ScoreData solutions can be deployed across multiple touch-points such as mobile, web, kiosk and store.
ScoreData solutions have been used by some of the largest companies in the world.
Show all 16 investments ↓
Experience · 26 entries
All (26)
Investments (22)
Founder (3)
Board (17)
2024
Board Member and Investor
Dec 2024
Seraphic is a leader in the rapidly growing Enterprise Browser Security market, driven by its patented technology that turns any browser into a secure browser with robust protection and detection capabilities.
Seamlessly and easily deployed, Seraphic also enables secure access to SaaS and private web applications to employees and third parties from managed and personal devices without the complexity and cost of VDI & VPN. Invisible to the end-user, Seraphic supports all browsers and SaaS desktop applications like Teams, Slack, Discord, and WhatsApp.
In January 2025, Seraphic announced raising $29 million in series A funding, with participation from the CrowdStrike Falcon Fund.
2022
L
Board Member and Investor, Linus Bio
Mar 2022
Linus Biotechnology is a patient-centric, breakthrough science, precision exposome medicine company. Our program pipeline comprises precision exposome medicine biomarkers and target discovery across disease domains for which historically no molecular endpoints have been available in medical practice or for clinical trials, including CNS (autism spectrum disorder, amyotrophic lateral sclerosis), gastroenterology (inflammatory bowel disease), renal disease and oncology.
Board Member and Investor
Mar 2022
Time to market can make or break any app dev project. Yet many enterprises, agencies, and developers slow innovation by burning countless hours building core functionality from scratch and extending development timelines.
But when you use the Onymos Features-as-a-Service platform, you get the features your app needs out of the box — and you can move fast from day one.
Founded in 2017 and based in Palo Alto, California, Onymos Features are deployed in apps on millions of devices today.
To learn more, please visit our website: www.onymos.com
2021
Board Member and Investor
Dec 2021
Were not a workforce management tool – were a workforce empowerment tool. As the leading cloud-based solution for the gig economy, Nowsta streamlines how businesses hire, schedule, and manage their flex workforce. Trusted by some of the largest brands in professional sports, hospitality, staffing, and more, Nowsta’s centralized platform is the fastest and easiest way to source workers, hire employees, organize schedules, track time & attendance, and improve communication. Founded in 2016, Nowsta’s mission is to equip both workers and businesses with an all-in-one platform to simplify and humanize staffing and labor-management processes, creating seamless, meaningful work experiences for the flex economy.
Board Member
Feb 2021
Excision BioTherapeutics is a private company focused on developing advanced gene editing therapeutics to address the medical need for the treatment of life-threatening disease caused by viral infections. Our mission is to advance gene editing therapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world.
Show all 26 entries ↓
Investment activity
2013–2024 · 23 investments
Recent (last 2 years)Earlier
